PT
Palatin Technologies, Inc.
PTN · NASDAQ
$9.48 +1.61% (+$0.15)
1M -25.24%
Market Cap $16.9M
P/E Ratio -
Div. Yield -
ROE 115.00%
Bulios Fair Price
$4.92
48.1% downside
Current Price
$9.48
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PTN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
87 /100
Cheap P/B 2.52x
P/S 1.28x
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 39.53%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 65.74%
Gross margin 97.48%
FCF margin 113.64%
Quality
15 /100
Poor ROA 98.29%
ROIC 125.44%
Asset turnover 1.55x
Debt
69 /100
Low Int. coverage -1,254.33x
Debt/Equity 0.03x
Current ratio 4.61x
Stability
19 /100
Unstable Profitable years 0
Beta -0.07x
EPS volatility 890.81%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PTN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Carl Spana
Employees
25
Headquarters
Monmouth Junction
Upcoming events
16 NOV
Earnings
Upcoming earnings report